Rapid Dose Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is March - February.

Millions CAD. Fiscal year is Mar - Feb.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2018 - 2020
Period Ending	Oct '25 Oct 31, 2025	Feb '25 Feb 28, 2025	Feb '24 Feb 29, 2024	Feb '23 Feb 28, 2023	Feb '22 Feb 28, 2022	Feb '21 Feb 28, 2021	2018 - 2020
Market Capitalization	24	22	21	9	26	17	Upgrade
Market Cap Growth	28.50%	6.81%	121.17%	-64.76%	56.16%	-36.29%	Upgrade
Enterprise Value	29	25	23	11	28	18	Upgrade
Last Close Price	0.18	0.17	0.17	0.09	0.26	0.21	Upgrade
PS Ratio	9.15	10.56	20.20	12.98	15.10	22.43	Upgrade
PB Ratio	-4.08	-4.23	-6.53	-3.49	105.16	-15.54	Upgrade
P/TBV Ratio	-	-	-	-	105.16	-	Upgrade
EV/Sales Ratio	11.13	11.79	23.00	15.75	15.81	24.39	Upgrade
Debt / Equity Ratio	-0.91	-0.50	-0.78	-0.79	5.70	-2.01	Upgrade
Asset Turnover	0.88	1.19	0.49	0.27	0.51	0.19	Upgrade
Inventory Turnover	5.39	4.25	2.79	1.67	1.26	0.43	Upgrade
Quick Ratio	0.09	0.05	0.13	0.04	0.09	0.08	Upgrade
Current Ratio	0.13	0.10	0.23	0.09	0.25	0.19	Upgrade
Return on Assets (ROA)	-71.41%	-148.14%	-93.37%	-83.34%	-77.93%	-25.16%	Upgrade
Return on Capital (ROIC)	-	-	-	-389.55%	-193.25%	-88.74%	Upgrade
Earnings Yield	-19.14%	-24.54%	-20.89%	-40.87%	-32.08%	-10.66%	Upgrade
FCF Yield	-3.85%	-5.23%	-11.13%	-9.27%	-11.49%	-9.64%	Upgrade
Buyback Yield / Dilution	-	-18.68%	-1.50%	-3.19%	-28.83%	-2.23%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.